MENU
+Compare
SMMT
Stock ticker: NASDAQ
AS OF
Jun 12 closing price
Price
$20.16
Change
+$0.58 (+2.96%)
Capitalization
14.54B

SMMT Summit Therapeutics Forecast, Technical & Fundamental Analysis

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more

Industry: #Biotechnology
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SMMT with price predictions
Jun 12, 2025

SMMT sees its Stochastic Oscillator climbs out of oversold territory

On June 05, 2025, the Stochastic Oscillator for SMMT moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 67 instances where the indicator left the oversold zone. In of the 67 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SMMT's RSI Indicator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SMMT advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

SMMT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SMMT as a result. In of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SMMT turned negative on May 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

SMMT moved below its 50-day moving average on May 30, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SMMT crossed bearishly below the 50-day moving average on June 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMMT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SMMT entered a downward trend on June 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SMMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (43.478) is normal, around the industry mean (16.792). P/E Ratio (26.355) is within average values for comparable stocks, (59.920). SMMT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.337). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (258.227).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SMMT is expected to report earnings to rise 33.14% to -9 cents per share on August 06

Summit Therapeutics SMMT Stock Earnings Reports
Q2'25
Est.
$-0.09
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.03
The last earnings report on May 01 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 3.64M shares outstanding, the current market capitalization sits at 14.54B.
A.I. Advisor
published General Information

General Information

a developer of novel medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
601 Brickell Key Drive
Phone
+1 650 460-8308
Employees
105
Web
https://www.smmttx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
UTK.X0.027677-0.001420
-4.88%
xMoney cryptocurrency
GAS.X2.909991-0.180969
-5.85%
Gas cryptocurrency
APT.X4.712955-0.313612
-6.24%
Aptos cryptocurrency
FIDA.X0.065740-0.005326
-7.49%
Solana Name Service (previously Bonfida) cryptocurrency
VIDT.X0.000583-0.000057
-8.96%
VIDT DAO cryptocurrency

SMMT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+2.96%
BCDA - SMMT
70%
Closely correlated
-2.22%
TIL - SMMT
52%
Loosely correlated
+2.58%
BNTX - SMMT
50%
Loosely correlated
-0.51%
VBIZF - SMMT
42%
Loosely correlated
N/A
FHTX - SMMT
41%
Loosely correlated
-0.87%
More

Groups containing SMMT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+2.96%
SMMT
(2 stocks)
98%
Closely correlated
+0.37%